PulseSight Therapeutics
PrivateLast Round
Series A
Feb 13, 2025
Total Funding Raised
$54.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PulseSight Therapeutics is a biotechnology company that develops non-viral gene therapies for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PulseSight Therapeutics Comparables
Compare PulseSight Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Complement Therapeutics | 82% | |
| Atsena Therapeutics | 79% | |
| Eli Lilly and Company | 78% | |
PulseSight Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2025 | ||||
| Seed | Feb 28, 2024 | ||||
| Series B Extension | Aug 4, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Sep 16, 2016 | ||||
VC Round | Apr 11, 2013 |
Key People
Founding team and executive leadership
PulseSight Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Seed, Series B Extension |
| Inserm Transfert | Series A, Seed, Series B, VC Round |
| Pontifax Venture Capital | Series A, Series B |
| +ND Capital | Seed |
| Pureos Bioventures | Series A, Series B, Seed |
| Boehringer Ingelheim Venture Fund | Series A, VC Round, Series B |
| Karista | Series A, Seed, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 43% MoM.
- Apr 24, 2026
Monthly visitors grew 50% MoM.
PulseSight Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PulseSight Therapeutics's valuation, stock price, and market status.